Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology ...

According to the World Health Organisation, a hygroma, more commonly referred to as a "cystic hygroma," is a benign tumour or malformation of the lymphatic system. It appears as a fluid-filled sac ...

in the evaluation of QTORIN™ rapamycin for treating microcystic lymphatic malformations. This decision follows favorable communication with the FDA, which has granted multiple designations to ...